Connect your AI

Ginkgo Bioworks DNA Reportable Segment — Merger and acquisition related expense (income)

Similar metrics at other companies

CNXCReportable Segment — Acquisition-related and integration expenses

$34.87M+93.5%

ADBEReportable Segment — Acquisition-related expenses

$5M—

NSCReportable Segment — Merger-related expenses

$52M—

PACBReportable Segment — Merger-related expenses

$0—

FULTReportable Segment — Acquisition-related expenses

$295.5K-96.9%

NSAReportable Segment — Merger related costs

$9.98M—

Other financials

Income statement

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's reportable segment — merger and acquisition related expense (income).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ginkgo Bioworks's reportable segment — merger and acquisition related expense (income)?: Ginkgo Bioworks (DNA) reported reportable segment — merger and acquisition related expense (income) of $0 in Q1 2026.
What does reportable segment — merger and acquisition related expense (income) mean?: This captures the costs or gains directly associated with the integration or acquisition of businesses within a specific segment. It is used to isolate the financial impact of inorganic growth activities from the segment's core operating performance.